CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Scientific Officer sold 10,470 shares at $70.00 ($732,900)
- 4 Open-market sale Chief Executive Officer sold 80,000 shares at $70.14 ($5,611,200)
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at $67.23 ($144,276)
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at $66.76 ($400,560)
- 4 Open-market sale Chief Executive Officer sold 35,000 shares at $67.12 ($2,349,200)
- 4 Open-market sale Director sold 4,000 shares at an average $65.59 ($262,360)
- 4 Open-market sale Chief Medical Officer sold 6,000 shares at $65.00 ($390,000)
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at $65.00 ($975,000)
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at $61.99 ($133,031)
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at $62.20 ($373,200)
- 4 Open-market sale Director sold 4,000 shares at an average $56.85 ($227,400)
- 4 Open-market sale Chief Scientific Officer sold 23,146 shares at an average $59.60 ($1,379,397)
- 4 Open-market sale Chief Executive Officer sold 27,000 shares at an average $59.95 ($1,618,560)
- 4 Open-market sale Director sold 9,000 shares at an average $56.36 ($507,260)
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at $55.00 ($118,030)
- 4 Open-market sale Chief Executive Officer sold 3,000 shares at $51.18 ($153,540)
- 4 Exercise or conversion Chief Scientific Officer acquired 3,000 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 4,292 shares at $55.00 ($236,060)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 24 of 38 · 758 filings